Orchestra BioMed Holdings (OBIO) Revenue Growth (1y) (2023 - 2026)
Orchestra BioMed Holdings (OBIO) Revenue Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 96.43% |
| 10 | Orchestra BioMed Holdings | 238.34 Mn | 143.94 Mn | 78,000.00 | -87.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.33% |
| Dec 31, 2025 | 12,120.16% |
| Sep 30, 2025 | -12.77% |
| Jun 30, 2025 | 7.46% |
| Mar 31, 2025 | 40.00% |
| Dec 31, 2024 | -3.44% |
| Sep 30, 2024 | 135.56% |
| Jun 30, 2024 | -14.97% |
| Mar 31, 2024 | -46.74% |
| Dec 31, 2023 | -76.25% |
| Sep 30, 2023 | -63.97% |
| Jun 30, 2023 | 128.18% |
| Mar 31, 2023 | 34.41% |